➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Boehringer Ingelheim
Merck
Baxter

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Clonazepam - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for clonazepam and what is the scope of freedom to operate?

Clonazepam is the generic ingredient in three branded drugs marketed by Alembic Pharms Ltd, Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Mylan, Mylan Pharms Inc, Prinston Inc, Rubicon, Sandoz, Teva, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Thirty-four suppliers are listed for this compound.

Drug Prices for clonazepam

See drug prices for clonazepam

Drug Sales Revenue Trends for clonazepam

See drug sales revenues for clonazepam

Recent Clinical Trials for clonazepam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Malmö UniversityN/A
Lund UniversityN/A
Queen Sirikit National Institute of Child HealthN/A

See all clonazepam clinical trials

Pharmacology for clonazepam
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for clonazepam

US Patents and Regulatory Information for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CLONAZEPAM clonazepam TABLET;ORAL 074964-001 Dec 30, 1997 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva CLONAZEPAM clonazepam TABLET;ORAL 074920-001 Aug 4, 1998 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Barr CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 077194-003 Aug 10, 2005 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sun Pharm Inds Inc CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 078654-004 Aug 27, 2014 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997 ⤷  Free Forever Trial ⤷  Free Forever Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982 ⤷  Free Forever Trial ⤷  Free Forever Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997 ⤷  Free Forever Trial ⤷  Free Forever Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Boehringer Ingelheim
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.